๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group phase III study

โœ Scribed by P Kirkbride; A Bezjak; J Pater; B Zee; R Wong; P Cross; S Gulavita; P Blood; A Sun; G Dundas; P.K Ganguly; J Lim; A.D Chowdhury; S.E Kumar; A.R Dar

Book ID
117747206
Publisher
Elsevier Science
Year
2001
Tongue
French
Weight
22 KB
Volume
5
Category
Article
ISSN
1278-3218

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II study of trimetrexate in malign
Phase II study of trimetrexate in malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group Study
โœ Neill A. Iscoe; Elizabeth A. Eisenhauer; Audley J. Bodurtha ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer US ๐ŸŒ English โš– 183 KB

The National Cancer Institute of Canada Clinical Trials Group carried out a phase II trial of trimetrexate given in a daily x 5 intravenous bolus schedule every 3 weeks in patients with measurable metastatic malignant melanoma who had not received previous chemotherapy. Significant hematologic toxic

Phase II study of flutamide in patients
Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study
โœ Daniele J. Perrault; Diane M. Logan; David J. Stewart; Vivien H. C. Bramwell; Al ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer US ๐ŸŒ English โš– 271 KB

The National Cancer Institute of Canada (NCIC) Clinical Trials Group conducted a phase II study of the oral antiandrogen flutamide in 33 patients with metastatic breast cancer. Eight patients had received no prior systemic therapy for their metastatic disease and 13 had only one site of metastasis.